Antimicrobial Pharmacodynamics: PK/PD Indices (T > MIC, Peak/MIC, AUC/MIC) (Clinical Treatise 2008)
Eradicating bacterial pathogens while suppressing the emergence of antimicrobial resistance demands alignment with specific class-dependent PK/PD drivers.
Pharmacological Mechanism & Kinetic Schema
Time-Dependent Killing of Beta-Lactams and Extended Infusions
Penicillins, Cephalosporins, and Carbapenems exhibit zero concentration-dependent killing once levels exceed 4 to 5 times the bacterial MIC. Clinical cure is determined strictly by the percentage of the dosing interval that unbound drug concentration exceeds MIC (%fT > MIC). Administering Meropenem or Piperacillin-Tazobactam as prolonged 3-to-4-hour infusions significantly elevates clinical survival in critically ill septic patients.
Concentration-Dependent Synergy of Aminoglycosides
For Gentamicin, Tobramycin, and Amikacin, the killing velocity and post-antibiotic suppression of regrowth depend entirely on achieving high peak-to-MIC ratios (Cmax/MIC >= 10). High-dose extended-interval dosing achieves rapid bacterial lysis while lowering trough exposure to prevent proximal tubule phospholipidosis.
Suppression of the Mutant Selection Window (MSW)
Sub-therapeutic antibiotic exposure within the Mutant Selection Window (between the MIC and the Mutant Prevention Concentration, MPC) selectively enriches resistant bacterial subpopulations. Maintaining clinical exposure targets above the MPC prevents the emergence of secondary resistance mutations.
Clinical Pharmacologist & Biochemist · Specialist in Pharmacokinetics & Hospital Pharmacotherapy · Published on March 26, 2008 at 01:10
O conteúdo deste artigo possui caráter exclusivamente informativo, educativo e de divulgação científica, baseado em literatura farmacêutica revisada por pares e diretrizes de Farmácia Baseada em Evidências. As informações não constituem recomendação terapêutica, diagnóstico clínico ou prescrição farmacêutica individualizada. Não substitui a consulta com um médico ou farmacêutico habilitado. Consulte sempre um profissional de saúde antes de iniciar, alterar ou descontinuar qualquer tratamento.
Conheça nossa Política Editorial, Fontes de Pesquisa e Metodologia Científica →
Dúvidas ou sugestão de correção editorial? Fale diretamente com a Redação ([email protected])
